Plain-English translation of NCT05111288 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called pulsed electromagnetic field (PEMF) therapy — a noninvasive device that delivers low-energy magnetic waves to your hands. Researchers believe this therapy may improve blood flow to your heart and reduce heart muscle damage in people with coronary artery disease. The study aims to confirm whether this treatment actually helps reduce the ischemia (lack of blood flow) that damages heart tissue.
Some patients with heart disease cannot have surgery or other interventions to restore blood flow. Early research suggests this therapy may help by improving how blood vessels work and increasing natural healing substances in the body, but larger studies are needed to prove it works.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to use either a real electromagnetic device or a sham (fake) device for 180 days. You will use the device three times daily for 16 minutes per session (48 minutes total per day) by placing it on your palms. Throughout the study, you will complete heart tests and exercise tests to measure whether blood flow to your heart has improved.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States